BARREGEN Trademark

Trademark Overview

On Wednesday, May 27, 2026, a trademark application was filed for BARREGEN with the United States Patent and Trademark Office. The USPTO has given the BARREGEN trademark a serial number of 99849037. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 27, 2026. This trademark is owned by Interpace Diagnostics, LLC. The BARREGEN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnostic molecular testing, monitoring and reporting services to aid in the diagnosis and mitigation of esophageal cancer
barregen

General Information

Serial Number99849037
Word MarkBARREGEN
Filing DateWednesday, May 27, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, May 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic molecular testing, monitoring and reporting services to aid in the diagnosis and mitigation of esophageal cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 27, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInterpace Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
US

Trademark Events

Event DateEvent Description
Wednesday, May 27, 2026APPLICATION FILING RECEIPT MAILED
Thursday, May 28, 2026NEW APPLICATION ENTERED

Related Keywords

barregen diagnosis mitigation esophageal cancer services reporting diagnostic molecular testing monitoring